European Healthtech startup funding raised during Q4 2013.
In Q4 2013, 30 European Healthtech companies raised a combined €187M across 30 funding rounds, up 40.1% versus Q4 2012. Switzerland led by capital raised, and Capricorn Venture Partners was the most active investor. Data as of 7 Aug 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Merus | Series B | Oct 2013 | €31M |
| Biocartis | Series D+ | Nov 2013 | €30M |
| ADC Therapeutics | Growth/Late | Oct 2013 | €30M |
| MISSION Therapeutics | Series B |
| Nov 2013 |
| €24M |
| Pixium Vision | Other | Nov 2013 | €15M |
| THERAVECTYS | Other | Oct 2013 | €15M |
| Morria Biopharmaceuticals | Other | Oct 2013 | €11M |
| Gecko Biomedical | Other | Dec 2013 | €9.9M |
| TROD Medical | Series B | Oct 2013 | €4.8M |
| iSTAR Medical | Series A | Nov 2013 | €4.0M |
| CartiHeal | Early VC | Oct 2013 | €3.7M |
| Opsona | Series C | Oct 2013 | €3.0M |
| Bioaxial | Other | Nov 2013 | €2.4M |
| Diagnosia | Seed | Oct 2013 | €1.0M |
| Angiodroid | Seed | Oct 2013 | €900k |
